I agree. Generex Biotechnology(GNBT) managed to get an app filed with BARDA while they were operating on fumes financially. The app was for their vaccine which isn't nearly advanced as leronlimab. Unfortunately they got caught in the switchover between BARDA and OWS and the government decided on nothing but rna and mrna vaccines to support. Point is, time and money was not why CYDY did not move forward. NP thinks he has the best product and wants to go it alone and not be a partner with the government. I bet he thought we would get EUA by now. Probably a mistake short term. Long term the jury is still out.